Desferrithiocin analogues and nephrotoxicity

被引:11
作者
Bergeron, Raymond J. [1 ]
Wiegand, Jan [1 ]
McManis, James S. [1 ]
Bharti, Neelam [1 ]
Singh, Shailendra [1 ]
机构
[1] Univ Florida, Dept Med Chem, Gainesville, FL 32610 USA
关键词
D O I
10.1021/jm8003398
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The syntheses of a series of 4'-O-alkylated (S)-4,5-dihydro-2-(2,4-dihydroxyphenyl)-4-methyl-4-thiazole-carboxylic acid and 5'-O-alkylated (S)-4,5-dihydro-2-(2,5-dihydroxyphenyl)-4-methyl-4-thiazoleearboxylic acid ligands are described. Their partition between octanol and water, 109 Pap,, is determined, along with their iron-clearing efficiency (ICE) in both non-iron-overloaded, bile duct-cannulated rodents and in iron-overloaded primates. The ligand-promoted biliary ferrokinetics in rats are described for each of the chelators. Plots of log P-app versus ICE in a rodent model for both the 4'-O-alkylated 2,4-dihydroxy and 5'-O-alkylated 2,5-dihydroxy series produced an inverse parabola plot with r(2) values of 0.97 and 0.81, respectively. The plots indicate an optimum log P-app/ICE relationship. Because of the nature of the data spread in the 4'-O-alkylated 2,4-dihydroxy series, it will be used to help assess the origin of nephrotoxicity in desferrithiocin analogues: is toxicity simply related to lipophilicity, ICE, or a combination of these properties?.
引用
收藏
页码:5993 / 6004
页数:12
相关论文
共 62 条
[21]   Iron chelators and iron toxicity [J].
Brittenham, GM .
ALCOHOL, 2003, 30 (02) :151-158
[22]   EFFICACY OF DEFEROXAMINE IN PREVENTING COMPLICATIONS OF IRON OVERLOAD IN PATIENTS WITH THALASSEMIA MAJOR [J].
BRITTENHAM, GM ;
GRIFFITH, PM ;
NIENHUIS, AW ;
MCLAREN, CE ;
YOUNG, NS ;
TUCKER, EE ;
ALLEN, CJ ;
FARRELL, DE ;
HARRIS, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (09) :567-573
[23]  
Brittenham GM, 2000, HEMATOLOGY BASIC PRI, P397
[24]  
Byers BR, 1998, MET IONS BIOL SYST, V35, P37
[25]   Iron-chelating therapy with the new oral agent ICL670 (Exjadee®) [J].
Cappellini, MD .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (02) :289-298
[26]   Insulin sensitivity and β-cell secretion in thalassaemia major with secondary haemochromatosis:: assessment by oral glucose tolerance test [J].
Cario, H ;
Holl, RW ;
Debatin, KMM ;
Kohne, E .
EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (03) :139-146
[27]   Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis [J].
Chua, ACG ;
Olynyk, JK ;
Leedman, PJ ;
Trinder, D .
BLOOD, 2004, 104 (05) :1519-1525
[28]   Iron absorption and transport [J].
Conrad, ME ;
Umbreit, JN ;
Moore, EG .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 318 (04) :213-229
[29]   AN EVALUATION OF NEPHROTOXICITY OF ETHYLENEDIAMINETETRAACETATE AND DIETHYLENETRIAMINEPENTAACETATE IN RAT [J].
DOOLAN, PD ;
SCHWARTZ, SL ;
HAYES, JR ;
MULLEN, JC ;
CUMMINGS, NB .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1967, 10 (03) :481-+
[30]   Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to β-thalassemia [J].
Galanello, R ;
Piga, A ;
Alberti, D ;
Rouan, MC ;
Séchaud, R .
JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (06) :565-572